Anti-VEGF
Treating Proliferative Diabetic Retinopathy
Whether it’s with anti-VEGF or PRP, patients’ outcomes may depend on their access to care and ability to follow up.
01/10/2023
Association Between Myopia and POAG/IOP
01/10/2023
An Update on the Anti-VEGF Biosimilar Pipeline
Biosimilars for diseases like AMD and diabetic retinopathy could possibly offer patients effective, less-costly options.
01/10/2023
Weathering the Storm of Neovascular Glaucoma
By the time your patients complain of symptoms, it may be too late. An expert shares how to manage this disease.
12/13/2022
Phase III Trials in Wet AMD—What’s Next?
A look at the drugs and devices closest to the clinical-trial finish line in the United States.
11/05/2020
